Age-related macular degeneration (AMD):

In vitro and in vivo studies of viral-delivered antiangiogenic effectors for development of antiangiogenic medicines with the perspective of possible clinical translation of neovessel inhibition treatment based on viral gene transfer technology.

Diabetic retinopathy:

Development of gene medicines to restore imbalanced production of neuroprotective factors related to diabetic retinopathy.

Inherited eye diseases:

Development of gene therapy to treat vision loss due to inherited ocular disease.